RANDOX EVIDENCE

Enzyme Immunoassay, Cocaine And Cocaine Metabolites

RANDOX LABORATORIES, LTD.

The following data is part of a premarket notification filed by Randox Laboratories, Ltd. with the FDA for Randox Evidence.

Pre-market Notification Details

Device IDK030360
510k NumberK030360
Device Name:RANDOX EVIDENCE
ClassificationEnzyme Immunoassay, Cocaine And Cocaine Metabolites
Applicant RANDOX LABORATORIES, LTD. 55 DIAMOND RD. Crumlin, County Antrim,  GB Bt29 4qy
ContactPauline Armstrong
CorrespondentPauline Armstrong
RANDOX LABORATORIES, LTD. 55 DIAMOND RD. Crumlin, County Antrim,  GB Bt29 4qy
Product CodeDIO  
Subsequent Product CodeDLJ
Subsequent Product CodeJJE
CFR Regulation Number862.3250 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2003-02-03
Decision Date2003-12-23

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05055273214024 K030360 000
05055273202694 K030360 000
05055273202663 K030360 000
05055273202656 K030360 000
05055273202458 K030360 000
05055273202397 K030360 000
05055273202335 K030360 000
05055273202137 K030360 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.